91 related articles for article (PubMed ID: 8332235)
21. Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis.
Greer JM; Pender MP
J Autoimmun; 2008 Nov; 31(3):281-7. PubMed ID: 18502611
[TBL] [Abstract][Full Text] [Related]
22. Pathogenesis of inflammatory demyelination: implications for therapy.
Hartung HP
Curr Opin Neurol; 1995 Jun; 8(3):191-9. PubMed ID: 7551118
[No Abstract] [Full Text] [Related]
23. Do human T-lymphotrophic viruses (HTLVs) and other enveloped viruses induce autoimmunity in multiple sclerosis?
Dalgleish AG; Fazakerley JK; Webb HE
Neuropathol Appl Neurobiol; 1987; 13(4):241-50. PubMed ID: 2821421
[TBL] [Abstract][Full Text] [Related]
24. A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses.
Venken K; Thewissen M; Hellings N; Somers V; Hensen K; Rummens JL; Stinissen P
J Immunol Methods; 2007 Apr; 322(1-2):1-11. PubMed ID: 17368474
[TBL] [Abstract][Full Text] [Related]
25. Antibody responses following induction of antigen-specific tolerance with antigen-coupled cells.
Peschl P; Reindl M; Schanda K; Sospedra M; Martin R; Lutterotti A
Mult Scler; 2015 Apr; 21(5):651-5. PubMed ID: 25200502
[TBL] [Abstract][Full Text] [Related]
26. [Experiences with the indirect Clausen Test using NTA as an antigen in multiple sclerosis and other neurologic diseases].
Dachsel R; Felber F; Liebert A
Psychiatr Neurol Med Psychol (Leipz); 1984 Jun; 36(6):350-6. PubMed ID: 6484061
[TBL] [Abstract][Full Text] [Related]
27. Physiopathology of multiple sclerosis.
Visconti A; Santucci S; Figà Talamanca L; Cannoni S; Ristori G; Salvetti M
Neurol Sci; 2003 Dec; 24 Suppl 5():S287-90. PubMed ID: 14652791
[TBL] [Abstract][Full Text] [Related]
28. Activation of myelin reactive T cells in multiple sclerosis: a possible role for T cell degeneracy?
Stinissen P; Hellings N
Eur J Immunol; 2008 May; 38(5):1190-3. PubMed ID: 18425726
[TBL] [Abstract][Full Text] [Related]
29. Bio-markers of disease activity and response to therapy in multiple sclerosis.
Miller A; Glass-Marmor L; Abraham M; Grossman I; Shapiro S; Galboiz Y
Clin Neurol Neurosurg; 2004 Jun; 106(3):249-54. PubMed ID: 15177778
[No Abstract] [Full Text] [Related]
30. [Multiple sclerosis].
Ochi H; Kira J
Ryoikibetsu Shokogun Shirizu; 2000; (31):47-51. PubMed ID: 11269138
[No Abstract] [Full Text] [Related]
31. Immune tolerance and control of CNS autoimmunity: from animal models to MS patients.
Cassan C; Liblau RS
J Neurochem; 2007 Feb; 100(4):883-92. PubMed ID: 17181557
[TBL] [Abstract][Full Text] [Related]
32. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets.
Holmøy T
Minerva Med; 2008 Apr; 99(2):119-40. PubMed ID: 18431322
[TBL] [Abstract][Full Text] [Related]
33. Antigen-Specific Immune Tolerance in Multiple Sclerosis-Promising Approaches and How to Bring Them to Patients.
Lutterotti A; Hayward-Koennecke H; Sospedra M; Martin R
Front Immunol; 2021; 12():640935. PubMed ID: 33828551
[TBL] [Abstract][Full Text] [Related]
34. Induction of immunological tolerance in chickens inoculated with xenogeneic antigens at an early stage of embryonic development.
Zhao C; Song C; Wang X; Li Z; Sha J; Han H; Zhang Y; Li Z
Dev Comp Immunol; 2006; 30(4):431-40. PubMed ID: 16150485
[TBL] [Abstract][Full Text] [Related]
35. Myelin peptides in multiple sclerosis.
Grau-López L; Raïch D; Ramo-Tello C; Naranjo-Gómez M; Dàvalos A; Pujol-Borrell R; Borràs FE; Martínez-Cáceres E
Autoimmun Rev; 2009 Jul; 8(8):650-3. PubMed ID: 19393199
[TBL] [Abstract][Full Text] [Related]
36. Immunobiology of oligodendrocytes in multiple sclerosis.
Ruffini F; Chojnacki A; Weiss S; Antel JP
Adv Neurol; 2006; 98():47-63. PubMed ID: 16400826
[No Abstract] [Full Text] [Related]
37. Using myelin antigen--coupled autologous cells for treatment of multiple sclerosis.
Bawany FI; Khan MS
J Pak Med Assoc; 2014 Jan; 64(1):115. PubMed ID: 24605733
[No Abstract] [Full Text] [Related]
38. MS study yields mixed results.
Yoon CK
Science; 1993 Feb; 259(5099):1263. PubMed ID: 8446895
[No Abstract] [Full Text] [Related]
39. Multiple sclerosis and autoimmunity.
Herndon RM
J Child Neurol; 1987 Oct; 2(4):242-3. PubMed ID: 3655205
[No Abstract] [Full Text] [Related]
40. Three-year open protocol continuation study of oral tolerization with myelin antigens in multiple sclerosis and design of a phase III pivotal trial.
Hohol MJ; Khoury SJ; Cook SL; Orav EJ; Hafler DA; Weiner HL
Ann N Y Acad Sci; 1996 Feb; 778():243-50. PubMed ID: 8610977
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
